Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Wusulijiang Pharmaceutical is a comprehensive Chinese pharmaceutical enterprise specializing in the research, development, and large-scale production of Traditional Chinese Medicine (TCM) and chemical pharmaceuticals. The company is a leading manufacturer of injectable drugs, with flagship products such as Ciwujia and Shuxuening injections widely used for cardiovascular and neurological conditions. Based in Jixi, Heilongjiang, the firm operates extensive GMP-certified facilities for various dosage forms, including tablets, capsules, and both large and small-volume injections. Its business model integrates the cultivation of medicinal herbs with industrial manufacturing to ensure a high-quality supply chain for the domestic healthcare market. The company is recognized as a National High-tech Enterprise and plays a significant role in the regional pharmaceutical economy of Northeast China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Wusulijiang Pharmaceutical.